Lyfius Pharma Pvt Ltd restarts operations at Penicillin-G manufacturing facility

Lyfius Pharma Private Limited (Lyfius), a wholly owned stepdown subsidiary of Aurobindo Pharma Ltd, has re-started the production, with immediate effect, after receiving the 'consent to operate (CTO)' from Andhra Pradesh Pollution Control Board (APPCB) for its Penicillin-G manufacturing facility, at Kakinada, Andhra Pradesh today, June 29, 2025.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1122.90 as compared to the previous close of Rs. 1123.15. The total number of shares traded during the day was 11901 in over 673 trades.

The stock hit an intraday high of Rs. 1138.45 and intraday low of 1119.50. The net turnover during the day was Rs. 13450498.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 LyfiusPharma ProductionRestart ConsentToOperate APPCB PenicillinG ManufacturingFacility